You are here

AusPAR: Nivolumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

31 March 2020
AusPAR Details
AusPAR
Active Ingredient
Nivolumab
Product Name
Opdivo
Sponsor
Bristol-Myers Squibb Australia Pty Ltd
Submission Number
PM-2017-03888-1-4
Submission Type
Major variation – new indication
Decision
Rejected
AusPAR Date
17 March 2020
Publication Date

31 March 2020